TTRX
Turn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.80
−2.68%Institutional positioning
13F filings over the trailing two quarters
New 4Increased 3Reduced 3Sold out 20
| Filer | Action | Shares | Filed |
|---|---|---|---|
| DDFG, INC | Increased | 70,534 | Apr 22, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 69,757 | May 15, 2026 |
| WELLINGTON SHIELDS & CO., LLC | Unchanged | 65,732 | May 4, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 49,450 | May 15, 2026 |
| TAMAR SECURITIES, LLC | Increased | 30,000 | May 14, 2026 |
| CITADEL ADVISORS LLC | New Position | 25,874 | Sep 2, 2026 |
| BROWN BROTHERS HARRIMAN & CO | Unchanged | 23,688 | May 14, 2026 |
| XTX TOPCO LTD | Reduced | 19,727 | May 15, 2026 |
| HIGHTOWER ADVISORS, LLC | Unchanged | 19,684 | May 5, 2026 |
| RVW WEALTH, LLC | Unchanged | 18,000 | Apr 8, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 17,142 | May 15, 2026 |
| MIRACLE MILE ADVISORS, LLC | Unchanged | 16,000 | Apr 8, 2026 |
| BANK OF AMERICA CORP /DE/ | Unchanged | 14,124 | May 18, 2026 |
| LPL FINANCIAL LLC | Increased | 13,300 | May 6, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 12,480 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings